Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Snake Venom Thrombin for Hemoptysis
NCT03270735Phase 4Unknown
- Sponsor
- Lee's Pharmaceutical Holdings Limited
- Start
- Jun 2017
- Primary completion
- Jun 2018
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial in hemoptysis (2 arms), sponsored by Lee's Pharmaceutical Holdings Limited. Primary endpoint: Adverse Events and Serious Adverse Events at 7 days. Status: unknown.
02
Conditions
hemoptysis
Beyond the preview
Go deeper on NCT03270735.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03270735.